Activist Sit Investment Associates boosts stake to 28.8% amid proxy fight, buying near 52-week lows
summarizeSummary
Activist investor Sit Investment Associates has increased its beneficial ownership in MFS Intermediate Income Trust to 28.8%, continuing to accumulate shares amidst an ongoing proxy battle over the company's future and buying near 52-week lows.
check_boxKey Events
-
Activist Stake Increased to 28.8%
Sit Investment Associates now beneficially owns 32,822,243 shares, representing 28.8% of MFS Intermediate Income Trust's common stock.
-
Significant Recent Purchases
The filing details continued share accumulation, including a substantial acquisition of 1,350,000 shares on May 7, 2026, valued at $3.375 million.
-
Proxy Fight Escalation
This increased ownership strengthens the activist's position in the ongoing battle against a proposed merger and their push to replace the company's investment adviser.
-
Buying Near 52-Week Lows
The recent share purchases by the activist occurred while the stock was trading near its 52-week lows, indicating strong conviction.
auto_awesomeAnalysis
This filing details the continued aggressive accumulation of shares by activist investor Sit Investment Associates, increasing their beneficial ownership to 28.8%. This significant increase, including a $3.375 million purchase on May 7, 2026, strengthens their position in the ongoing proxy battle. Notably, these purchases occurred while the stock was trading near its 52-week lows, suggesting strong conviction from the activist. Sit Investment Associates has previously filed to formally oppose a proposed merger and is pushing for a change in the company's investment adviser. The increased stake gives them more voting power to influence the outcome of the upcoming special shareholder meeting regarding the adviser replacement, making the outcome of this corporate governance struggle more uncertain for current management.
At the time of this filing, MIN was trading at $2.48 on NYSE in the Unknown sector, with a market capitalization of approximately $281.1M. The 52-week trading range was $2.44 to $2.73. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.